DipCatcherDipCatcher by KAWUMS
Market
AAL.L3,971.00 p+2.8%AAPL$332.41+0.3%ACN$189.64-1.9%ADA$0.1985+1.6%ADBE$250.50-2.8%ADS.DE€143.85+1.4%AIR.DE€198.66+1.8%ALGO$0.0898+1.1%ALV.DE€450.50+1.3%AMD$512.50+1.6%AMZN$245.96-1.0%ANTO.L3,637.00 p+3.9%ATOM$1.54+1.2%AUTO.L502.20 p+1.4%AV.L724.40 p+1.7%AVAX$7.54+3.7%AVGO$339.51+0.1%AXP$312.43-3.7%AZN.L12,268.00 p+1.3%BA.L2,050.82 p+2.2%BAC$57.90-2.7%BARC.L479.70 p+2.0%BAS.DE€52.18+0.7%BATS.L4,247.00 p+0.6%BAYN.DE€49.34+1.3%BCH$221.59+2.1%BEI.DE€75.06+0.8%BMW.DE€63.34+0.8%BNB$725.17+1.8%BNZL.L2,624.00 p+1.3%BP.L565.80 p-2.5%BRK-B$519.80+0.6%BT-A.L207.00 p+1.6%BTC$76,456.06+1.1%C$132.95-2.4%CAT$782.72-0.1%CBK.DE€41.60-2.0%CCH.L4,620.00 p+0.3%CON.DE€70.74+3.2%COST$893.74-0.8%CPG.L31.04 p-1.1%CRDA.L3,158.00 p+0.1%CRM$250.54-2.0%CSCO$107.74-2.1%CVX$211.54-2.9%DB1.DE€278.00+0.2%DBK.DE€33.65+0.9%DGE.L1,633.50 p+1.5%DHER.DE€36.72-0.1%DHL.DE€55.96+0.3%DIS$106.99+0.5%DOGE$0.0811+1.3%DOT$1.01+7.0%DTE.DE€28.93+0.1%ENT.L507.00 p+1.7%EOAN.DE€17.72+1.9%ETC$7.43+3.3%ETH$2,445.95+2.0%EVT.DE€2.83+0.9%EXPN.L2,826.05 p+0.9%FME.DE€40.24+1.2%FRE.DE€46.33+2.1%G24.DE€75.75+1.5%GFT.DE€26.15-1.5%GLEN.L574.80 p-0.2%GOOGL$342.87-0.6%GS$937.98-4.0%GSK.L1,889.00 p+1.9%GXI.DE€27.72-0.3%HD$302.47-1.0%HEI.DE€150.85+1.2%HEN3.DE€74.12+1.7%HNR1.DE€256.60+0.5%HON$207.66+2.1%HSBA.L1,526.20 p+1.5%IBM$237.49-4.4%IFX.DE€54.25-0.1%III.L2,693.00 p+3.6%IMB.L2,515.00 p-0.0%INTC$101.05+4.0%JMAT.L2,288.00 p+0.5%JNJ$267.28+0.0%JPM$348.92-1.0%KGX.DE€42.10+1.7%LAND.L640.50 p+2.5%LGEN.L302.10 p+2.7%LHA.DE€7.68+1.7%LINK$11.17+2.6%LLOY.L111.60 p+2.5%LLY$1,137.82+0.2%LOW$194.10-0.3%LSEG.L8,208.00 p+0.1%LTC$52.64+2.7%LXS.DE€13.65+0.1%MA$567.75-1.0%MBG.DE€46.11-1.0%MDT$92.60-1.2%META$673.31+0.5%MNG.L338.64 p+1.6%MS$202.42-1.9%MSFT$490.30-1.4%MTX.DE€341.10+2.3%MUV2.DE€514.40+0.3%NDA.DE€165.80+1.2%NDX1.DE€39.16+1.1%NEE$80.37-0.9%NFLX$76.41-1.9%NG.L1,142.00 p+2.9%NOW$139.82-1.5%NVDA$213.90+0.8%OCDO.L218.61 p+5.7%ORCL$143.16+2.0%PAH3.DE€29.14-0.4%PEP$134.34-0.9%PG$147.02+0.2%PM$191.71-1.2%PRU.L990.40 p+1.7%PSN.L1,171.00 p+6.6%PUM.DE€22.52+3.3%QCOM$184.84-1.6%QIA.DE€37.63+1.2%REL.L2,577.80 p+1.6%RIO.L7,233.00 p+1.2%RKT.L5,026.00 p-0.8%RMV.L502.80 p+1.0%RR.L1,470.20 p+3.5%RWE.DE€60.56+3.9%SAP.DE€187.48+0.2%SAX.DE€36.64-0.1%SBRY.L337.20 p+0.1%SBUX$97.34+0.8%SDF.DE€16.68+1.4%SGE.L1,026.50 p+1.9%SGRO.L944.40 p+1.0%SHEL.L3,578.00 p-2.0%SHIB$0.0000+0.8%SHL.DE€38.58-0.7%SIE.DE€263.90+2.0%SOL$99.98+3.2%SSE.L2,433.00 p+4.3%STAN.L2,311.00 p+2.0%SY1.DE€90.62+1.4%T$25.86-3.2%TKA.DE€15.34+1.2%TRX$0.3351+0.7%TSCO.L480.70 p+0.3%TSLA$358.08+0.4%TXN$260.67-1.0%ULVR.L4,662.00 p+0.4%UNH$375.26-0.2%UNP$280.92-1.1%UPS$98.77-3.5%V$370.93-1.2%VNA.DE€17.99-0.1%VOD.L131.60 p+0.3%VOW3.DE€80.02-1.2%WEIR.L2,680.00 p+3.2%WMT$107.50-0.5%WPP.L382.40 p-0.4%XLM$0.1829+3.8%XOM$163.32-3.5%XRP$1.30+1.3%ZAL.DE€21.59-0.7%
Dips
HON-17.1%Buy VNA.DE-16.9%Buy OCDO.L-22.3%Watch FME.DE-7.8%Watch BA.L-12.1%Watch ADS.DE-15.5%Watch AUTO.L-10.6%Watch G24.DE-8.6%Watch GOOGL-10.8%Watch LLY-12.0%Watch

AZN.L

LSE

AstraZeneca PLC

Healthcare · Drug Manufacturers - General

12,268.00 p
+1.3% today · just now

Price

-6.7% · 3 months
1m3m6m
12,204.46 p13,006.21 p13,807.97 psignal18/06/202603/08/202617/09/2026
High 14,537.04 p · 02/07/2026Low 11,460.00 p · 14/08/2026

Verdict

signal 4 h ago
HOLD-2.9% below 30-day high

No buyable dip: 2.9% below its 30-day high. Nothing to do here.

Sign in to watch

Catalysts

7 min ago
News, last 10 days
neutral +0.0210 articles
Next earnings
30/10/2026 · in 43 days
Last report
27/07/2026 +6.3% vs estimate

Trade levels

Free account · 3 tickers a day

Why the engine says so

Free account · 3 tickers a day

History for this ticker

Free account · 3 tickers a day

Watch and alert

Free account · 3 tickers a day

About AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company has a collaboration agreement with IonQ, Inc. for the development of quantum-accelerated computational chemistry workflow for healthcare, life sciences, and chemistry; a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and collaboration Revna Biosciences for lung cancer treatment. AstraZeneca PLC was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Headquarters:
Cambridge, United Kingdom
52-week range:
9,892.00 p – 15,732.00 p
Website:
astrazeneca.com

Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search